Gypenoside XIII

Gypenoside XIII is belonging to the gypenosides. Gypenosides, extracted from Gynostemma pentaphyllum, have various pharmacological properties and protect against cardiovascular diseases, especially atherosclerosis[1].

Product Specifications

CAS Number

[80325-22-0]

UNSPSC

12352005

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/gypenoside-xiii.html

Purity

99.13

Solubility

Ethanol : 50 mg/mL (ultrasonic)

Smiles

C[C@]12[C@@](C[C@@H](O)[C@@]3([H])[C@]2(CC[C@]3([H])[C@@](CC/C=C(C)/C)(C)O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO[C@H]5[C@@H]([C@H]([C@H](O)CO5)O)O)C)([H])[C@@]6([C@@](C(C)([C@@H](O)CC6)C)([H])CC1)C

Molecular Formula

C41H70O12

Molecular Weight

754.99

References & Citations

[1]Yang K, et al. Gypenoside XVII Prevents Atherosclerosis by Attenuating Endothelial Apoptosis and Oxidative Stress: Insight into the ERα-Mediated PI3K/Akt Pathway. Int J Mol Sci. 2017 Feb 9;18 (2) .